Yale SPORE in Lung Cancer Career Enhancement Program
Yale SPORE in Lung Cancer Career Enhancement Program
批准号:
10203858
负责人:
Harriet M. Kluger
金额:
$7.98万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-08-26 至 2025-07-31
关键词:
AddressAppointmentAreaAwardBasic ScienceBiochemistryBiologicalBiophysicsCancer BiologyCollaborationsColon CarcinomaCommunitiesDevelopmentDiagnosisDisciplineFacultyFellowship ProgramFosteringFoundationsFundingGenerationsGeneticGoalsGrowthHumanInfrastructureInstitutionMalignant neoplasm of lungMalignant neoplasm of prostateMalignant neoplasm of thoraxMedicalMedical OncologyMedical ResearchMentorsMinority RecruitmentMolecularPathologyPatientsPharmacologyPhysiciansPreventionProceduresProcessPulmonologyResearchResearch PersonnelScienceScientistSeedsSolidTalentsTrainingTranslational ResearchUnited States National Institutes of HealthWorkYale Cancer Centeranticancer researchbasecareerclinical centerclinical investigationdesigninterestknowledge basemalignant breast neoplasmmedical schoolsnext generationnovelpersonalized medicineprogramsrecruittranslational impacttranslational research programtranslational scientist
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROGRAM SUMMARY
The number of physician-scientists working in lung cancer has not kept pace with the overall growth of the
medical research community or with the growth in our basic knowledge base, resulting in an increasing number
of unrealized basic and translational research opportunities. Yale is uniquely suited to helping rebuild this base
with our strong commitment to translational research. The Career Enhancement Program (CEP) of the Yale
SPORE in Lung Cancer (YSILC) has been designed to contribute substantively to ongoing efforts and new
initiatives attempting to address this problem. The goal of the CEP is to educate a new generation of
investigators committed to translational research in lung cancer. The CEP has substantial institutional
commitment, both in terms of funding and infrastructure. For example, our translational research office at Yale
(also led by Dr. Herbst, YSILC PI) has been committed to providing early seed funding and translational
support to young investigators early in their research careers. Potential CEP candidates include promising
junior faculty who are interested in establishing their careers in translational lung cancer research and/or
established investigators whose previous research has been in other areas and would like to transition into
lung cancer focused research. Junior faculty awardees will be paired with mentors who are more established
lung cancer investigators with a documented record of successful mentoring. In this way, the YSILC will
stimulate the development of the next generation of physician scientists, addressing the most challenging
issues in lung cancer research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dual-isotope SPECT imaging and immunophenotyping of immune cells to determine response to immunotherapy
-
批准号:10590408
-
项目类别:
-
资助金额:$66.8万
-
财政年份:2023
-
负责人:Harriet M. Kluger
-
依托单位:
The Yale Cancer Center Calabresi Immuno-Oncology Training Program (IOTP)
-
批准号:9899739
-
项目类别:
-
资助金额:$90.75万
-
财政年份:2018
-
负责人:Harriet M. Kluger
-
依托单位:
YALE CANCER CENTER CALABRESI IMMUNO-ONCOLOGY TRAINING PROGRAM
-
批准号:10646793
-
项目类别:
-
资助金额:$58.24万
-
财政年份:2018
-
负责人:Harriet M. Kluger
-
依托单位:
A research and training program for junior clinicians in treating metastatic mela
-
批准号:8581535
-
项目类别:
-
资助金额:$15.61万
-
财政年份:2013
-
负责人:Harriet M. Kluger
-
依托单位:
A research and training program for junior clinicians in treating metastatic mela
-
批准号:8692684
-
项目类别:
-
资助金额:$15.61万
-
财政年份:2013
-
负责人:Harriet M. Kluger
-
依托单位:
A research and training program for junior clinicians in treating metastatic mela
-
批准号:9279067
-
项目类别:
-
资助金额:$15.61万
-
财政年份:2013
-
负责人:Harriet M. Kluger
-
依托单位:
Models to Predict Prognosis and Benefit from Adjuvant Therapy in Renal Cell Carci
-
批准号:8613470
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2011
-
负责人:Harriet M. Kluger
-
依托单位:
Models to predict prognosis and benefit from adjuvant therapy in renal cell carci
-
批准号:8085276
-
项目类别:
-
资助金额:$38.12万
-
财政年份:2011
-
负责人:Harriet M. Kluger
-
依托单位:
Models to predict prognosis and benefit from adjuvant therapy in renal cell carci
-
批准号:8236884
-
项目类别:
-
资助金额:$35.81万
-
财政年份:2011
-
负责人:Harriet M. Kluger
-
依托单位:
Models to predict prognosis and benefit from adjuvant therapy in renal cell carci
-
批准号:8444714
-
项目类别:
-
资助金额:$33.32万
-
财政年份:2011
-
负责人:Harriet M. Kluger
-
依托单位:
Project 4-Modulating Innate Immunity to Overcome Resistance to PD-1/PD-L1 Blockade
-
批准号:10468767
-
项目类别:
-
资助金额:$31.12万
-
财政年份:2006
-
负责人:Harriet M. Kluger
-
依托单位:
Predicting Melanoma Response to BAY 43-9006/Chemotherapy
-
批准号:6955905
-
项目类别:
-
资助金额:$29.06万
-
财政年份:2005
-
负责人:Harriet M. Kluger
-
依托单位:
Predicting Melanoma Response to BAY 43-9006/Chemotherapy
-
批准号:7078609
-
项目类别:
-
资助金额:$28.38万
-
财政年份:2005
-
负责人:Harriet M. Kluger
-
依托单位:
Predicting Melanoma Response to BAY 43-9006/Chemotherapy
-
批准号:7434028
-
项目类别:
-
资助金额:$26.89万
-
财政年份:2005
-
负责人:Harriet M. Kluger
-
依托单位:
Predicting Melanoma Response to BAY 43-9006/Chemotherapy
-
批准号:7251921
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2005
-
负责人:Harriet M. Kluger
-
依托单位:
Cancer Research Career Enhancement and Related Activities
-
批准号:10228171
-
项目类别:
-
资助金额:$11.9万
-
财政年份:1997
-
负责人:Harriet M. Kluger
-
依托单位:
Cancer Research Career Enhancement and Related Activities
-
批准号:10461898
-
项目类别:
-
资助金额:$11.9万
-
财政年份:1997
-
负责人:Harriet M. Kluger
-
依托单位:
Project 4-Modulating Innate Immunity to Overcome Resistance to PD-1/PD-L1 Blockade
-
批准号:9766214
-
项目类别:
-
资助金额:$33.23万
-
财政年份:--
-
负责人:Harriet M. Kluger
-
依托单位:
Project 4-Modulating Innate Immunity to Overcome Resistance to PD-1/PD-L1 Blockade
-
批准号:9567749
-
项目类别:
-
资助金额:$35.18万
-
财政年份:--
-
负责人:Harriet M. Kluger
-
依托单位:
海外基金